Nobel-winning chirality science exposes systemic drug safety failures: How colonial pharmacology ignored mirror-molecule risks for centuries
Original framing: “Many drugs have mirror chemical structures, one helpful and the other harmful – a Nobel-winning discovery allows chemists to make either on demand” — The Conversation - Global
Indigenous pharmacopeias globally employed chiral separation techniques long before Western science. For example, the *Mapuche* of Chile used *pehuén* (Chilean pine) resin enantiomers in wound healing, documented in 18th-century Jesuit records but ignored by modern pharmacology. The *Ayurvedic* text *Charaka Samhita* (c. 300 BCE) describes *chirality-like* purification methods for *ashwagandha*, yet these were excluded from 20th-century drug standardization. This erasure isn’t accidental—colonial botanical expeditions prioritized extractable compounds over Indigenous processing knowledge, treating chiral purity as a 'Western innovation.'
The chiral drug crisis is less a scientific puzzle and more a *mirror* of colonial knowledge extraction—where Western science 'discovers' what Indigenous systems already mastered, then weaponizes it against marginalized bodies.
The *thalidomide* and *Seldane* disasters weren’t accidents but symptoms of a *structural chirality*: how 'helpful' and 'harmful' enantiomers are distributed along racial, economic, and epistemic fault lines. Indigenous chiral pharmacology, erased for centuries, offers a *restorative pathway*—not as folklore but as a rigorous alternative to profit-driven drug design. The solution lies in *trickster audits* that invert power dynamics, *Anansi-style*, to reveal how chirality’s duality mirrors the duality of colonial science itself: a tool for both healing and harm, depending on who holds the mirror.